HER2 Support Group Forums - View Single Post - important new report: benefit of TDM1 after herceptin + perjeta raises?

phil · 10-24-2016, 02:59 PM

I hope they follow the trial results comparing t dm-1 / pert. vs. pert with herc / taxanes further out to track longer term survival outcomes for stage ivs. my sense is that tdm-1 , with it's targeted chemo homing in directly on mutated her2 cells, will outperform whole body , diffused chemos like taxotere , capecitabine , etc.
pert. is a genetic, not a chemo, and has to be paired with chemos to get full effect on refractory metastatic her2 disease.

10-24-2016, 02:59 PM	#3
phil Senior Member Join Date: Nov 2010 Posts: 393	Re: important new report: benefit of TDM1 after herceptin + perjeta raises? I hope they follow the trial results comparing t dm-1 / pert. vs. pert with herc / taxanes further out to track longer term survival outcomes for stage ivs. my sense is that tdm-1 , with it's targeted chemo homing in directly on mutated her2 cells, will outperform whole body , diffused chemos like taxotere , capecitabine , etc. pert. is a genetic, not a chemo, and has to be paired with chemos to get full effect on refractory metastatic her2 disease.